American gastroenterological association technical review on the diagnosis and management of asymptomatic neoplastic pancreatic cysts

JM Scheiman, JH Hwang, P Moayyedi - Gastroenterology, 2015 - gastrojournal.org
Pancreatic cysts are being identified with increasing frequency as a result of the escalating
use of crosssectional imaging, typically for unrelated reasons. 1, 2 The incidence of …

Systematic review, meta-analysis, and a high-volume center experience supporting the new role of mural nodules proposed by the updated 2017 international …

G Marchegiani, S Andrianello, A Borin, C Dal Borgo… - Surgery, 2018 - Elsevier
Abstract Background Mural nodules (MNs) have a predominant role in the 2016 revision of
the international guidelines on intraductal papillary mucinous neoplasms (IPMN) of the …

Meta-analysis of mortality in patients with high-risk intraductal papillary mucinous neoplasms under observation

G Vanella, S Crippa, L Archibugi… - Journal of British …, 2018 - academic.oup.com
Background Although consensus guidelines suggest that patients with high-risk intraductal
papillary mucinous neoplasms (IPMNs) should have surgery, a non-operative strategy is …

[HTML][HTML] Endoscopic ultrasound-guided fine-needle aspiration plus KRAS and GNAS mutation in malignant intraductal papillary mucinous neoplasm of the pancreas

B Bournet, A Vignolle-Vidoni, D Grand… - Endoscopy …, 2016 - thieme-connect.com
Background: KRAS and GNAS mutations are common in intraductal papillary mucinous
neoplasia of the pancreas (IPMN). The aims of this study were to assess the role of pre …

[HTML][HTML] Outcomes of nonresected main-duct intraductal papillary mucinous neoplasms of the pancreas

M Daudé, F Muscari, C Buscail, N Carrère… - World Journal of …, 2015 - ncbi.nlm.nih.gov
AIM: To compare characteristics and outcomes of resected and nonresected main-duct and
mixed intraductal papillary mucinous neoplasms of the pancreas (IPMN). METHODS: Over a …

Should we regard all main duct type intraductal papillary mucinous neoplasms of the pancreas (MD-IPMN) as an indication of surgery?-A retrospective study in 29 …

Y Masaki, S Koshita, Y Noda, Y Kanno, T Ogawa… - Pancreatology, 2019 - Elsevier
Purpose To elucidate predictive factors for malignant main duct type IPMN (MD-IPMN).
Methods All 29 subjects had mural nodules (MNs) in the main pancreatic duct (MPD) on …

Oncocytic intraductal papillary mucinous neoplasms of the pancreas: imaging and histopathological findings

M D'Onofrio, R De Robertis, PT Martini, P Capelli… - Pancreas, 2016 - journals.lww.com
Objectives To evaluate and correlate computed tomography/magnetic resonance findings
and histopathologic features of oncocytic intraductal papillary mucinous neoplasms (O …

Risk factors for malignant progression of intraductal papillary mucinous neoplasms

M Moris, M Raimondo, TA Woodward, V Skinner… - Digestive and Liver …, 2015 - Elsevier
Background Intraductal papillary mucinous neoplasms of the pancreas are increasingly
diagnosed. Due to their malignant potential, greater understanding of their nature is …

Serum N-glycan profiles in patients with intraductal papillary mucinous neoplasms of the pancreas

Y Akimoto, K Nouso, H Kato, K Miyahara, C Dohi… - Pancreatology, 2015 - Elsevier
Background/objectives Diagnosing the invasiveness of intraductal papillary mucinous
neoplasms (IPMNs) is difficult, especially by blood test. Alterations in serum glycan profiles …

Intraductal papillary mucinous neoplasms and mucinous cystadenomas: current status and recommendations.

M Moris, MB Wallace - Revista Espanola de Enfermadades Digestivas …, 2017 - go.gale.com
The real prevalence of pancreatic cystic lesions remains unknown. The malignant potential
of some of these lesions remains a cause for significant concern. Thus, it is mandatory to …